Feel Comfortable Switching Many Patients to Clopidogrel Early After a Stent

November 2017

You'll face questions about whether it's okay for patients to switch antiplatelet meds after a coronary stent.

Current guidelines prefer dual antiplatelet therapy with aspirin plus Brilinta (ticagrelor) or Effient (prasugrel) after an acute coronary syndrome...instead of aspirin plus clopidogrel.

Earlier studies suggest that Brilinta or Effient reduces the risk of a recurrent CV event more than clopidogrel...but causes more bleeding.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote